Current Gene Therapy
Volume 22, 5 Issues, 2022
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
Thematic Issue Proposal
Guest Editors who wish to submit an issue proposal to Current Gene Therapy are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Current Gene Therapy who will then inform Guest Editors with a decision about the submitted proposal.
Editor-in-Chief
Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)
Biography
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
Biography
Biography of Liang Cheng
Dr. Cheng obtained a doctorate (Ph.D.) in Bioinformatics from Harbin Institute of Technology, Harbin, Heilongjiang, China. Currently Dr. Cheng is a Professor and PI of Biological Software Engineering in Harbin Medical University. He has published more than 70 scientific publications since 2013. Dr. Cheng develops novel algorithms and tools for gene therapy of Type 2 Diabetes Mellitus and complex diseases.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Webmaster Contact: info@benthamscience.net